MedCap Advisors
3
5M
3
- Areas of investment
Summary
The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Cambridge.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cerapedics.
The typical case for the fund is to invest in rounds with 2 participants. Despite the MedCap Advisors, startups are often financed by OrbiMed. The meaningful sponsors for the fund in investment in the same round are OrbiMed. In the next rounds fund is usually obtained by OrbiMed, NGN Capital.
The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2007. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Investments by industry
- Biotechnology (2)
- Health Care (1)
- Medical Device (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cerapedics | 05 Oct 2007 | Biotechnology, Health Care, Medical Device | Early Stage Venture | 16M | United States, Colorado, Westminster |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.